E-poster Presentation 2014 World Cancer Congress

Pim-1 acts as an oncogene in human salivary adenoid cystic carcinoma (#1053)

Xin Zhu 1 , Sisi Hu 1 , Jianguo Feng 1 , Zhiqiang Ling 1 , Minghua Ge 1
  1. Zhejiang Cancer Hospital, Hangzhou, China


Pim-1 (Provirus integration site for Moloney murine leukemia virus 1) belongs to the Ser/Thr kinase family and plays a pivotal role in occurrence and development of oncogenesis. Recent studies have demonstrated that Pim-1 phosphorylates RUNX3 and alters its subcellular localization. As a highly malignant tumor, salivary adenoid cystic carcinoma (ACC) accounts for approximately 10% of all epithelial salivary tumors and the 5-year survival rate of patients with highly metastatic ACC is less than 20%. However, few studies have concerned the implications of Pim-1 in the salivary ACC.


In this study, we aimed to clarify the function of Pim-1 in ACC cell lines in vitro. Meanwhile, we measure the levels of Pim-1 and RUNX3 in the ACC tissues. The correlations between Pim-1/RUNX3 levels and clinical parameters were also analyzed.


SACC-83 and SACC-LM cells were transfected with the Pim-1 siRNA. Pim-1 mRNA and protein expression were measured using real-time PCR and immnuoblot, respectively. Cell proliferation was analyzed by CCK-8 assay. Cell cycle, apoptosis, and mitochondrial membrane potential were detected by flow cytometry. Effects of Pim-1 on cells’ invasion were evaluated by transwell migration assay. Pim-1 and RUNX3 levels in ACC tissues were examined by immunohistochemistry.


Pim-1 siRNA reduces cell proliferation, induces apoptosis, causes cell cycle arrest, mitochondrial depolarization, and decreases invasive ability in SACC-83 and SACC-LM cells. Pim-1 and RUNX3 levels are negative relevant and significantly associated with T-stage and nerve invasion in the ACC tissues.


This study demonstrates the oncogenic role of Pim-1 in ACC. The findings also suggest that Pim-1 may serve as a neoteric therapeutic target and potential prognostic marker for ACC cancer.

  1. Moskaluk CA. Adenoid cystic carcinoma: clinical and molecular features. Head Neck Pathol. 2013,7(1):17-22.
  2. Liu J, Shao C, Tan ML, Mu D, Ferris RL, Ha PK. Molecular biology of adenoid cystic carcinoma.Head Neck. 2012, 34(11):1665-77.
  3. Chuang LS, Ito K, Ito Y. RUNX family: Regulation and diversification of roles through interacting proteins. Int J Cancer. 2013, 132(6):1260-71.
  4. He JF, Ge MH, Zhu X, Chen C, Tan Z, Li YN, Gu ZY. Expression of RUNX3 in salivary adenoid cystic carcinoma: Implications for tumor progression and prognosis. Cancer Science. 2008; 99(7):1334-40.
  5. Kim HR, Oh BC, Choi JK, et al. Pim-1 kinase phosphorylates and stabilizes RUNX3 and alters its subcellular localization.J Cell Biochem. 2008, 105(4):1048-58.
  6. Aho TL, Sandholm J, Peltola KJ, et al. Pim-1 kinase phosphorylates RUNX family transcription factors and enhances their activity. BMC Cell Biol. 2006, 9;7:21.
  7. Nawijn MC, Alendar A, Berns A. For better or for worse: the role of Pim oncogenes in tumorigenesis.Nat Rev Cancer. 2011, 11(1):23-34.
  8. Magnuson NS, Wang Z, Ding G, et al. Why target PIM1 for cancer diagnosis and treatment? Future Oncol. 2010, 6(9):1461-78.